Fenfluramine treatment and seizure-free days in pediatric and adult patients with Lennox-Gastaut syndrome: A post hoc analysis.
The most common primary endpoint for assessing treatment efficacy in patients with Lennox-Gastaut syndrome (LGS) is change in frequency of seizures associated with a fall. Increased number of seizure-free days (SFDs) is more strongly associated with improved quality of life than seizure frequency reduction. Fenfluramin...